James C. Hamilton
CIK: 0001830755
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARROWHEAD PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Apr 23, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct10K shares at avg. $75.00$750K - Mar 5, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct10K shares at avg. $64.19$642K - Jan 6, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Award(A)Direct75K shares- - Jan 5, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct12.7K shares at avg. $63.95$813K - Jan 5, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $64.49$77K - Jan 5, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct437 shares at avg. $65.97$29K - Jan 5, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct309 shares at avg. $68.00$21K - Jan 5, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct14.8K shares at avg. $63.01$932K - Jan 5, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct4.6K shares at avg. $61.24$283K - Jan 5, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct6.1K shares at avg. $62.28$379K - Oct 1, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct20K shares at avg. $35.00$700K - Sep 12, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct15K shares at avg. $30.00$450K - Sep 2, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct15K shares at avg. $25.00$375K - Aug 15, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct9.4K shares at avg. $20.00$188K - Aug 13, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct611 shares at avg. $20.00$12K - Jan 6, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct21.8K shares at avg. $19.68$428K - Jan 6, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct11K shares at avg. $20.11$221K - Jan 4, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Award(A)Direct100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 23, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 10,000 | $75.00 | $750,000 | Direct |
| Mar 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 10,000 | $64.19 | $641,900 | Direct |
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award(A) | 75,000 | - | $0 | Direct |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 12,711 | $63.95 | $812,868 | Direct |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 1,200 | $64.49 | $77,388 | Direct |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 437 | $65.97 | $28,829 | Direct |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 309 | $68.00 | $21,012 | Direct |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 14,792 | $63.01 | $932,044 | Direct |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 4,625 | $61.24 | $283,235 | Direct |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 6,090 | $62.28 | $379,285 | Direct |
| Oct 1, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 20,000 | $35.00 | $700,000 | Direct |
| Sep 12, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 15,000 | $30.00 | $450,000 | Direct |
| Sep 2, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 15,000 | $25.00 | $375,000 | Direct |
| Aug 15, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 9,389 | $20.00 | $187,780 | Direct |
| Aug 13, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 611 | $20.00 | $12,220 | Direct |
| Jan 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 21,758 | $19.68 | $428,197 | Direct |
| Jan 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 10,971 | $20.11 | $220,627 | Direct |
| Jan 4, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award(A) | 100,000 | - | $0 | Direct |
1-18 of 18 transactions
About Hamilton James C
Hamilton James C (SEC CIK 0001830755) files insider reports with the SEC as Chief Medical Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR).
Signal8 holds 9 ownership filings by Hamilton James C, all Form 4s, filed between Jan 7, 2025 and Apr 24, 2026. Those filings report 18 transactions, from Jan 4, 2025 to Apr 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hamilton James C's filings is in PASADENA, CA.
Recent filings by Hamilton James C
- Apr 23, 2026: Open-market sale of ARWR shares (Form 4, code S).
- Mar 5, 2026: Open-market sale of ARWR shares (Form 4, code S).
- Jan 6, 2026: Grant or award of ARWR shares (Form 4, code A).
- Jan 5, 2026: Open-market sales of ARWR shares (7 lines, Form 4, code S).
- Oct 1, 2025: Open-market sale of ARWR shares (Form 4, code S).
Other insiders filing for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
- OLUKOTUN ADEOYE Y, Director
- PERRY MICHAEL S, Director
- Cohen Matthew Gregory, Director
- Lu Hongbo, Director
- Apel Daniel Joseph, Chief Financial Officer
- O'Brien Patrick, COO